FDA seeks action against stem cell clinics

The US Food and Drug Administration has requested permanent injunctions against stem cell clinics in two regions of the country to prevent them from administering unapproved stem cell treatments to patients with cancer and other diseases. The move comes nearly 10 months after it issued warning letters to the clinics.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States